Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/LISATA-THERAPEUTICS-INC-30403115/news/Caladrius-Biosciences-Receives-SAKIGAKE-Expedited-Review-Designation-in-Japan-for-CLBS12-for-Treatin-26313336/?utm_source=whatsapp&utm_medium=social&utm_campaign=share